// App-Quantinova.ai

SP0011 : COMPLEMENT ACTIVATION AND ANTIPHOSPHOLIPID SYNDROME

Researchers

Presenter

  • J. Salmon

Principal Investigators

  • N/A

Medical Centers

  • Rheumatology, Hospital for Special Surgery, New York, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Lupus

  • Placental insufficiency

  • Vasodilation dysfunction

  • Spontaneous abortion

  • Preeclampsia

  • Venous thrombosis

Biomarkers

  • Complement Component 5a

Drug/Treatment

  • Eculizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved